|
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid |
|
CHEBI:140238 |
|
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid |
|
An oxodocosahexaenoic acid that is (4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid in which the oxo group is located at position 17. An intermediate of specialised proresolving mediators. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H30O3/c1-2-3-15-18-21(23)19-16-13-11-9-7-5-4-6-8-10-12-14-17-20-22(24)25/h3,5-8,11-16,19H,2,4,9-10,17-18,20H2,1H3,(H,24,25)/b7-5-,8-6-,13-11-,14-12-,15-3-,19-16+ |
QCEBQMMZCFADMF-VIIQGJSXSA-N |
C(C(O)=O)C/C=C\C/C=C\C/C=C\C\C=C/C=C/C(C/C=C\CC)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
PPARalpha agonist
A PPAR modulator which activates the peroxisome proliferator-activated receptor-alpha.
PPARgamma agonist
A PPAR modulator which activates the peroxisome proliferator-activated receptor-gamma.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
has role
anti-inflammatory agent
(CHEBI:67079)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
has role
antineoplastic agent
(CHEBI:35610)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
has role
human xenobiotic metabolite
(CHEBI:76967)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
has role
PPARα agonist
(CHEBI:70782)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
has role
PPARγ agonist
(CHEBI:71554)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
is a
enone
(CHEBI:51689)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
is a
oxodocosahexaenoic acid
(CHEBI:134542)
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
is conjugate acid of
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoate
(CHEBI:140316)
|
|
Incoming
|
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoate
(CHEBI:140316)
is conjugate base of
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid
(CHEBI:140238)
|
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosa-4,7,10,13,15,19-hexaenoic acid
|
17-oxo-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoic acid
|
ChEBI
|
17-oxo-DHA
|
SUBMITTER
|
17-oxodocosahexaenoic acid
|
ChEBI
|
26960428
|
Reaxys Registry Number
|
Reaxys
|
24594225
|
PubMed citation
|
Europe PMC
|
26339618
|
PubMed citation
|
Europe PMC
|
27337155
|
PubMed citation
|
Europe PMC
|
27883019
|
PubMed citation
|
Europe PMC
|
29435611
|
PubMed citation
|
Europe PMC
|
|